Purdue Pharma L.P.

Track this case

Case overview

Case Number:

7:19-bk-23649

Court:

New York Southern

Nature of Suit:

Firms

Companies

Government Agencies

Sectors & Industries:

September 13, 2021
Purdue Pharma Gets OK For $7.1M In Exec Incentives

A New York bankruptcy judge gave Purdue Pharma permission Monday to make incentive payments of up to $7.1 million to its top executives, rejecting arguments that the executives had not done enough to clean up the company's corporate culture.
September 01, 2021
Purdue Pharma Ch. 11 Plan Gets OK With Sackler Releases

A New York bankruptcy judge on Wednesday approved OxyContin maker Purdue Pharma's Chapter 11 plan, including contentious opioid liability releases for the company's now-former Sackler family owners.
August 27, 2021
Sacklers Agree To Forgo Non-Opioid Ch. 11 Releases

Purdue Pharma told a New York bankruptcy judge on Friday that its owners in the Sackler family will no longer be getting releases for non-opioid liability, but liability immunity related to opioid claims will remain, as the hearing on the final decision on its Chapter 11 plan has been postponed.
August 25, 2021
Purdue Ch. 11 Judge Says Sackler Releases Should Be Tighter

A New York bankruptcy judge on Wednesday urged Purdue Pharma to narrow the nonopioid liability releases it is granting members of its owning Sackler family as he prepared to make his judgment on Purdue's Chapter 11 plan on Friday.
August 23, 2021
No More Speeches, Settle This Ch. 11, Purdue Judge Urges

Telling the parties Monday that "the time has passed at this point to speechify," the New York bankruptcy judge overseeing Purdue Pharma's bankruptcy urged the objecting states and the owning members of the Sackler family to settle their differences before the confirmation hearing resumes Wednesday.
August 19, 2021
Judge Urges Attention To Individual Stories In Purdue Ch. 11

The sixth day of evidence in Purdue Pharma's Chapter 11 plan confirmation hearing ended Thursday with the judge walking off camera after a declaration that the damage individuals have suffered in the opioid crisis should not be lost in the complexities of the bankruptcy case.
August 18, 2021
Ex-Purdue Chair Denies Blame For Opioid Crisis

A former president and board chairman of Purdue Pharma on Wednesday denied that the company or its owners in the Sackler family bore responsibility for the United States' opioid crisis as the confirmation hearing for Purdue's Chapter 11 plan entered its fifth day.
August 17, 2021
Sacklers Say They'll Fight Any Attempt To Foil Ch. 11 Releases

A member of the Purdue Pharma-owning Sackler family told a New York bankruptcy judge Tuesday that his family will not settle opioid claims without the releases in the company's proposed Chapter 11 plan and promised protracted fights against attempts to seek damages outside of bankruptcy.
August 16, 2021
Sackler Reps Say They Can't Sell Assets Without Releases

The liability releases for Purdue Pharma-owning members of the Sackler family in its Chapter 11 plan must stand in order for a court in the British Crown dependency of Jersey to release assets needed to fund the $4.5 billion settlement at its center, family representatives told a New York bankruptcy court Monday.
August 13, 2021
Sacklers' Ch. 11 Releases Are Fair, Supporting States Say

States and other government bodies that consented to Purdue Pharma's Chapter 11 plan defended the plan's liability releases for members of the Sackler family as the confirmation trial entered its second day Friday, arguing that it's a fair deal to fund opioid abatement.

← Previous
…
5
6
7
8
9
10
11
12
13
…
Next →